VLA-1に対する抗体

Japanese Patent JP2004536580

A

Antibodies that specifically bind to VLA-1 integrin and methods of using these antibodies to treat immunological disorders in a subject. Also included are crystal structures of complexes formed by VLA-1 antibodies and their ligands, and VLA-1 antagonists and agonists identified by using the structure coordinates of these structures.

WO/2021/113644	COMBINATIONS COMPRISING A CD8+ T CELL ENHANCER, AN IMMUNE CHECKPOINT INHIBITOR AND RADIOTHERAPY FOR TARGETED AND ABSCOPAL EFFECTS FOR THE TREATMENT OF CANCER
JPH11137249	NEW BMRU
WO/2020/160310	DNA-ENCODED BISPECIFIC T-CELL ENGAGERS TARGETING CANCER ANTIGENS AND METHODS OF USE IN CANCER THERAPUTICS

Line, Paul Dee.
Gerber, Ellen Aye.
Saldanha, Jose W.
Carpsus, michael

JP2002582193A

December 09, 2004

April 12, 2002

Click for automatic bibliography generation  

Biogen Idec MA Inc.

A61K39/395; A61K49/16; A61P29/00; A61P37/00; C07H21/04; C07K16/18; C07K16/24; C07K16/28; G01N33/50; C07K16/46; C12N1/00; C12N5/10; C12N5/12; C12N5/20; C12N5/22; C12N9/00; C12N15/07; C12N15/09; C12N15/11; C12N15/13; G01N33/15; G01N33/53; G01N33/543; G01N33/567; G01N33/577; G06F17/00; G06F17/30; H04N9/64; H04N13/02; H04N15/00; C12N; (IPC1-7): C12N15/09; A61K39/395; A61P29/00; C07K16/28; C12N5/10; G06F17/30

Hidesaku Yamamoto
Takaaki Yasumura
Natsuki Morishita

Previous Patent: 血管内皮増殖因子２

Next Patent: 分泌される可能性のあるタンパク質をコードする全長ヒトｃＤＮＡ